| 1683 |
1487: Binding, SH/SeH proteins involved in protection against oxidative stress |
177: Mitochondrial dysfunction |
Nov 9, 2017 |
Nov 9, 2017 |
None
|
| 1689 |
1487: Binding, SH/SeH proteins involved in protection against oxidative stress |
1392: Oxidative Stress |
Nov 9, 2017 |
Feb 7, 2018 |
None
|
| 1765 |
1487: Binding, SH/SeH proteins involved in protection against oxidative stress |
1538: Protection against oxidative stress, decreased |
Sep 13, 2018 |
Feb 10, 2020 |
1 AOP
|
| 2250 |
1831: Binding, Thyroid binding globulin in serum |
1830: Displacement, Serum thyroxine (T4) from carrier protein |
Dec 9, 2020 |
Dec 9, 2020 |
1 AOP
|
| 2245 |
957: Binding, Transthyretin in serum |
958: Displacement, Serum thyroxine (T4) from transthyretin |
Dec 9, 2020 |
Dec 9, 2020 |
1 AOP
|
| 2248 |
957: Binding, Transthyretin in serum |
1830: Displacement, Serum thyroxine (T4) from carrier protein |
Dec 9, 2020 |
Dec 9, 2020 |
1 AOP
|
| 2269 |
957: Binding, Transthyretin in serum |
961: Increased, Clearance of thyroxine from serum |
Jan 26, 2021 |
Jan 26, 2021 |
None
|
| 2271 |
957: Binding, Transthyretin in serum |
959: Increased, Free serum thyroxine (T4) |
Jan 26, 2021 |
Jan 26, 2021 |
None
|
| 714 |
718: Binding, Tubulin |
720: Disruption, Microtubule dynamics |
Nov 29, 2016 |
May 27, 2019 |
1 AOP
|
| 724 |
718: Binding, Tubulin |
723: Altered, Chromosome number |
Nov 29, 2016 |
Dec 13, 2019 |
1 AOP
|
| 330 |
301: Binding, VEGF-A |
304: Decreased, VegfR2 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 331 |
301: Binding, VEGF-A |
305: Inhibition, VegfR2 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2025 |
1716: STAT5 inhibition |
1717: Suppression of STAT5 binding to cytokine gene promoters |
Jan 5, 2020 |
Nov 3, 2021 |
1 AOP
|
| 1755 |
1529: Blockade, L-Type Calcium Channels |
1530: Decrease, Calcium currents |
Jun 19, 2018 |
Jun 19, 2018 |
1 AOP
|
| 3406 |
1529: Blockade, L-Type Calcium Channels |
698: Altered, Action Potential |
Nov 20, 2024 |
Nov 20, 2024 |
1 AOP
|
| 1813 |
1570: Blocking of IL-1R |
1572: Impaired IL-1 signaling |
Dec 24, 2018 |
Jun 25, 2019 |
None
|
| 1973 |
1676: Blood extravasation into the lungs |
1679: Acute inhalation toxicity |
Jul 3, 2019 |
Jul 3, 2019 |
None
|
| 1170 |
1132: Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tis |
1135: Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2353 |
1867: Bradykinin, activated |
1496: Increased proinflammatory mediators |
Apr 20, 2021 |
Jan 14, 2022 |
1 AOP
|
| 2355 |
1867: Bradykinin, activated |
1866: Hypofibrinolysis |
Apr 20, 2021 |
Jan 24, 2022 |
1 AOP
|
| 2357 |
1867: Bradykinin, activated |
1868: Hyperinflammation |
Apr 20, 2021 |
Oct 19, 2021 |
1 AOP
|
| 3654 |
2093: Decreased brain T4/T3 |
1656: TR Antagnoism |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 3658 |
2093: Decreased brain T4/T3 |
381: BDNF, Reduced |
Oct 8, 2025 |
Oct 8, 2025 |
1 AOP
|
| 2398 |
1879: Bulky DNA adducts, increase |
155: Inadequate DNA repair |
May 17, 2021 |
May 17, 2021 |
1 AOP
|
| 2399 |
1879: Bulky DNA adducts, increase |
185: Increase, Mutations |
May 17, 2021 |
Sep 14, 2021 |
1 AOP
|